Interaction of kendomycin and semi-synthetic analogues with the anti-apoptotic protein Bcl-xl

Bioorg Med Chem Lett. 2008 Nov 1;18(21):5771-3. doi: 10.1016/j.bmcl.2008.09.071. Epub 2008 Sep 23.

Abstract

The cytotoxic macrolide kendomycin was identified as a ligand of Bcl-xl, an anti-apoptotic member of the Bcl-2 protein family. Hydrolysis-stable and protonable semi-synthetic analogues have been obtained that retain cytotoxicity and Bcl-xl binding.

MeSH terms

  • Apoptosis / drug effects*
  • Cell Line, Tumor
  • Humans
  • Rifabutin / analogs & derivatives*
  • Rifabutin / chemistry
  • Rifabutin / pharmacology
  • bcl-X Protein / chemistry*

Substances

  • bcl-X Protein
  • kendomycin
  • Rifabutin